Civic Intelligence

The Progeria Research Foundation Inc.

990 • Fiscal year 2019 • EIN 04-3460220

Jan 01, 2019 to Dec 31, 2019 • Filed on Sep 23, 2020

PO Box 3453Peabody, MA 01961-3453

(978) 535-2594

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

37th percentile

0.07x

Higher debt load relative to assets than 37% of similar nonprofits.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2019

Liabilities / Revenue

39th percentile

0.10x

Higher debt load relative to revenue than 39% of similar nonprofits.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2019

Net Margin

90th percentile

48%

Higher net margin than 90% of similar nonprofits.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2019

Top Officer Pay

61st percentile

$146,696

Higher top officer pay than 61% of similar nonprofits.

Top officer pay equals 2.9% of source-year revenue.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2019

Asset Growth

93rd percentile

48%

Faster asset growth than 93% of similar nonprofits.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2018 to 2019

Revenue Growth

92nd percentile

75%

Faster revenue growth than 92% of similar nonprofits.

2019 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2018 to 2019

Assets

Up

$7,451,058

Up $2,425,716 (+48%) from 2018

Net Assets

Up

$6,942,443

Up $2,400,304 (+53%) from 2018

Liabilities

Up

$508,615

Up $25,412 (+5.3%) from 2018

Revenue

Up

$5,046,788

Up $2,162,071 (+75%) from 2018

Expenses

Up

$2,646,484

Up $124,965 (+5.0%) from 2018

Net Income

Up

$2,400,304

Up $2,037,106 (+561%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$60M$40M$20M$0Assets 2010: $2,820,342Liabilities 2010: $25,996Net Assets 2010: $2,794,3462010Assets 2011: $3,562,853Liabilities 2011: $108,431Net Assets 2011: $3,454,4222011Assets 2012: $3,735,811Liabilities 2012: $50,247Net Assets 2012: $3,685,5642012Assets 2013: $4,234,880Liabilities 2013: $202,870Net Assets 2013: $4,032,0102013Assets 2014: $5,081,358Liabilities 2014: $433,323Net Assets 2014: $4,648,0352014Assets 2015: $4,308,161Liabilities 2015: $433,949Net Assets 2015: $3,874,2122015Assets 2016: $4,779,872Liabilities 2016: $385,355Net Assets 2016: $4,394,5172016Assets 2017: $4,511,886Liabilities 2017: $332,945Net Assets 2017: $4,178,9412017Assets 2018: $5,025,342Liabilities 2018: $483,203Net Assets 2018: $4,542,1392018Assets 2019: $7,451,058Liabilities 2019: $508,615Net Assets 2019: $6,942,4432019Assets 2020: $6,950,071Liabilities 2020: $418,027Net Assets 2020: $6,532,0442020Assets 2021: $53,690,802Liabilities 2021: $337,042Net Assets 2021: $53,353,7602021Assets 2022: $47,596,733Liabilities 2022: $772,349Net Assets 2022: $46,824,3842022Assets 2023: $48,844,685Liabilities 2023: $593,519Net Assets 2023: $48,251,1662023Assets 2024: $48,028,500Liabilities 2024: $627,829Net Assets 2024: $47,400,6712024

Highlighted filing

2019

Assets$7,451,058
Liabilities$508,615
Net Assets$6,942,443

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MRevenue 2010: $1,703,301Expenses 2010: $1,241,034Net Income 2010: $462,2672010Revenue 2011: $2,028,547Expenses 2011: $1,368,471Net Income 2011: $660,0762011Revenue 2012: $1,806,700Expenses 2012: $1,575,558Net Income 2012: $231,1422012Revenue 2013: $2,718,395Expenses 2013: $2,371,949Net Income 2013: $346,4462013Revenue 2014: $2,741,632Expenses 2014: $2,579,078Net Income 2014: $162,5542014Revenue 2015: $2,015,719Expenses 2015: $2,823,533Net Income 2015: -$807,8142015Revenue 2016: $3,172,499Expenses 2016: $2,652,194Net Income 2016: $520,3052016Revenue 2017: $2,147,287Expenses 2017: $2,362,863Net Income 2017: -$215,5762017Revenue 2018: $2,884,717Expenses 2018: $2,521,519Net Income 2018: $363,1982018Revenue 2019: $5,046,788Expenses 2019: $2,646,484Net Income 2019: $2,400,3042019Revenue 2020: $2,209,540Expenses 2020: $2,619,939Net Income 2020: -$410,3992020Revenue 2021: $49,219,762Expenses 2021: $3,160,686Net Income 2021: $46,059,0762021Revenue 2022: $1,793,850Expenses 2022: $3,126,766Net Income 2022: -$1,332,9162022Revenue 2023: $2,231,500Expenses 2023: $3,929,965Net Income 2023: -$1,698,4652023Revenue 2024: $3,650,308Expenses 2024: $5,902,368Net Income 2024: -$2,252,0602024

Highlighted filing

2019

Revenue$5,046,788
Expenses$2,646,484
Net Income$2,400,304
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Sep 23, 2020
Return Version
2019v5.1
Gross Receipts
$5,086,605
Mission and Program Overview

Mission

Discover treatments & cure for progeria & its aging related disorders, including heart disease.

Discover treatments & cure for progeria & its aging-related disorders, including heart disease.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$4,490,236$6,609,595▲ $2,119,359
Investments Other Securities$216,103$511,136▲ $295,033
Pledges and Grants Receivable$188,738$151,293▼ $37,445
Intangible Assets$91,598$89,454▼ $2,144
Land, Buildings, and Equipment, Net$16,759$44,011▲ $27,252
Prepaid Expenses and Deferred Charges$18,908$42,569▲ $23,661
Total Assets$5,025,342$7,451,058▲ $2,425,716
Other Assets Total$3,000$3,000→ $0
Liabilities
Accounts Payable and Accrued Expenses$483,203$481,162▼ $2,041
Other Liabilities$0$27,453▲ $27,453
Total Liabilities$483,203$508,615▲ $25,412
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$4,387,973$6,919,947▲ $2,531,974
Net Assets With Donor Restrictions$154,166$22,496▼ $131,670
Total Net Assets Fund Balance$4,542,139$6,942,443▲ $2,400,304
Total Liabilities and Net Assets / Fund Balance$5,025,342$7,451,058▲ $2,425,716

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$39,808$45,250$85,058
Leasehold Improvements$4,203$2,929$7,132
Other Securities$511,136--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Audrey GordonPresidentFT$122,669$24,027$146,696

Board Members and Trustees

NameTitle
John MarozziDirector
Karen BallackDirector
Kim ParatoreDirector
Larry MillsDirector
Liza MorrisDirector
Sandra BresnickDirector
Scott BernsDirector
TOM O'BRIENDirector
Paula KellyTreasurer/director
Barbara GordonClerk
Revenue and Support

Revenue Composition

Contributions and Grants
$4,778,810
Program Service Revenue
$0
Investment Income
$102,997
Other Revenue
$164,981
All Other Contributions
$4,529,158
Change in Net Assets
$2,400,304

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Securities Publicly Traded2$99,510Market Quote
Total Noncash Contributions2$99,510-

Audited Revenue Reconciliation

Revenue per Audited Statements
$5,046,788
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$387,862
Total Revenue per Audited Statements
$5,434,650
Total Revenue per Form 990
$5,046,788
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$1,825,325
Salaries, Compensation, and Employee Benefits$708,375
Total Fundraising Expense$157,397
Grants and Similar Amounts Paid$112,784
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$252,609$133,135$83,155$468,899
All Other Expenses$300,470$43,615$15,586$359,671
Current Officers, Directors, Trustees, and Key Employees$79,735$18,400$24,534$122,669
Other Expenses$98,014--$98,014
Grants to Domestic Orgs$70,909--$70,909
Payroll Taxes$35,830$16,178$10,154$62,162
Other Employee Benefits$29,674$16,846$8,125$54,645
Occupancy$9,966$40,320-$50,286
Foreign Grants$41,875--$41,875
Fees for Services Accounting-$31,960-$31,960
Fees for Services Other$6,328$8,550$14,592$29,470
Depreciation Depletion$16,246$5,702-$21,948
Office Expenses-$20,637-$20,637
Insurance-$6,075-$6,075
Travel$1,983$2,751$1,251$5,985
Fees for Services Legal$5,010--$5,010
Total Functional Expenses$2,144,918$344,169$157,397$2,646,484

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$3,034,346
Expenses per Audited Statements$2,646,484
Total Expenses per Form 990$2,646,484
Expenses Not Reported on Form 990$387,862
Expenses Not Reported on Financial Statements$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of PennsylvaniaPhiladelphia, PA-Medical Research$52,159
University of California San FranciscoSan Francisco, CA-Medical Research$18,750

International Summary

Offices
0
Employees
0
Spending
$23,125

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland)Grant Making-00$23,125
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Gross Income$204,798
Fundraising Direct Expenses$39,817
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Onepossible$156,016-$10,992-
Now Gala$139,912$136,483-$136,483
Total Events$409,084$204,798$39,817$164,981
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Refundable Advances$27,453
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

Audrey gordon who is the president is the sister of leslie gordon who is the volunteer medical director. Barbara gordon who is the clerk is the mother of audrey gordon who is the president and leslie gordon who is the volunteer medical director. Scott berns, who is a director and husband of leslie gordon (volunteer medical director), the brother in law of audrey gordon (president) and son in law of barbara gordon (clerk).

Form 990, Part VI, Section B, Line 11B

The 990 is reviewed by the president, executive director and the treasurer.

Form 990, Part VI, Section B, Line 12C

Discussed at annual board meetings.

Form 990, Part VI, Section B, Line 15

The president's salaries for 2019 were determined by the independent voting members after review of the duties performed and data as to comparable compensation for similarly qualified persons. There were no other compensated officers or key employees in 2019.

Form 990, Part VI, Section C, Line 19

All documents are available upon request, financial statements are also available on the organization website.

Filing and Contact Details

Filer

Filer Name
Progeria Research Foundation Inc
EIN
04-3460220
Phone
9785352594
Address
PO BOX 3453, PEABODY, MA 01961-3453

Signing Officer

Name
Audrey Gordon Esq
Title
President, Executive Director
Phone
9785352594
Signed
2020-09-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Audrey Gordon Esq
Formed
1999
Legal Domicile
Ma
Voting Board Members
9
Independent Board Members
8
Employees
13
Volunteers
1,000

Preparer

Firm
Litmangerson Associates Llp
Address
500 W CUMMINGS PARK SUITE 5650, WOBURN, MA 01801
Preparer
Marci J Cohen
Phone
7815694700
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 4D, Other Program Services

Diagnostic testing: prf developed a diagnostic test for progeria in the wake of the 2003 gene discovery so that children, their families and medical caretakers can for the first time be given a definitive scientific diagnosis. This can translate into earlier diagnosis, fewer misdiagnoses and early medical intervention to ensure a better quality of life for the children. Medical & research database: the database is a collection of medical records of progeria patients from all over the world. The data is rigorously analyzed to determine the best course of treatments to improve the patients' quality of life. This information is invaluable for the attending physician to guide the family through the best course of action. Database material was used to create prf's comprehensive healthcare recommendations handbook on progeria aimed at optimizing quality of life. The database was also critical in determining the primary clinical outcome parameter for the progeria clinical drug trials. Website/public awareness: in 2019, the prf website was updated. Progeriaresearch.org provides visitors with access to the latest information on progeria research, support, and education for families and caregivers. In addition, prf's social media presence and media exposure help raise awareness of the ultra-rare disease globally. Prf translation program: in touch with the world. With a prominent global outreach, prf eliminates barriers of communication for patients and their families around the world. This initiative has succeeded in translating prf program and medical care materials into over 38 different languages. The foundation edits and publishes the progeria handbook, a guide for families and health care providers of children with progeria. It is published in english and several other languages to allow its use throughout the world. The foundation maintains an international progeria registry containing centralized information on children and families living with progeria. This assures rapid distribution of any new information that may benefit the children. Prf organizes scientific conferences that bring together scientists and clinicians from all over the world to share their expertise and cutting edge scientific data, and foster collaboration in the fight against progeria and other aging related illnesses.

Form 990, Part IX, Line 24E

Diagnostic testing: program service expenses 84,612. Management and general expenses 0. Fundraising expenses 0. Total expenses 84,612. Medical and research database: program service expenses 80,263. Management and general expenses 0. Fundraising expenses 0. Total expenses 80,263. Media expense: program service expenses 71,638. Management and general expenses 0. Fundraising expenses 0. Total expenses 71,638. Postage and shipping: program service expenses 16,267. Management and general expenses 6,303. Fundraising expenses 15,586. Total expenses 38,156. Printing: program service expenses 31,149. Management and general expenses 787. Fundraising expenses 0. Total expenses 31,936. Computer expenses: program service expenses 0. Management and general expenses 21,517. Fundraising expenses 0. Total expenses 21,517. Patient handbooks: program service expenses 16,541. Management and general expenses 0. Fundraising expenses 0. Total expenses 16,541. Online processing fees: program service expenses 0. Management and general expenses 11,491. Fundraising expenses 0. Total expenses 11,491. Dues and subscriptions: program service expenses 0. Management and general expenses 2,006. Fundraising expenses 0. Total expenses 2,006. Professional development: program service expenses 0. Management and general expenses 1,511. Fundraising expenses 0. Total expenses 1,511.

FORM 990, PART XII, LINE 2C:

The organization has not changed its oversight process or selection process during the tax year.

Financial Statement Notes

PART X, LINE 2:

The organization accounts for the uncertainty in income taxes in accordance with the provisions of fasb asc topic no. 740 income taxes (asc 740), which prescribes a recognition threshold of more likely-than-not, and a measurement attribute for all tax positions taken or expected to be taken on a tax return, in order for those tax positions to be recognized in the financial statements. When necessary, the organization accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes. The organization does not expect that unrecognized tax benefits arising from tax positions will change significantly within the next 12 months.

Raw XML AppendixShowing 400 of 564 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0483203
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0481162
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0DISCOVER TREATMENTS & CURE FOR PROGERIA & ITS AGING-RELATED DISORDERS, INCLUDING HEART DISEASE.
IRS990/AllOtherContributionsAmt04529158
IRS990/AllOtherExpensesGrp/FundraisingAmt015586
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt043615
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0300470
IRS990/AllOtherExpensesGrp/TotalAmt0359671
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum09785352594
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO BOX 3453
IRS990/BooksInCareOfDetail/USAddress/CityNm0PEABODY
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd0019613453
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt024534
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt018400
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt079735
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0122669
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0204286
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt04778810
IRS990/CYGrantsAndSimilarPaidAmt0112784
IRS990/CYInvestmentIncomeAmt0102997
IRS990/CYOtherExpensesAmt01825325
IRS990/CYOtherRevenueAmt0164981
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt02400304
IRS990/CYSalariesCompEmpBnftPaidAmt0708375
IRS990/CYTotalExpensesAmt02646484
IRS990/CYTotalFundraisingExpenseAmt0157397
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt05046788
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt05702
IRS990/DepreciationDepletionGrp/ProgramServicesAmt016246
IRS990/DepreciationDepletionGrp/TotalAmt021948
IRS990/Desc0RESEARCH GRANTS: PRF HAS AWARDED 76 RESEARCH GRANTS TOTALING $8.37 MILLION THROUGH PEER REVIEW BY OUR VOLUNTEER MEDICAL RESEARCH COMMITTEE. AWARDS OF UP TO $100,000 PER YEAR, FOR UP TO THREE YEARS, HAVE ALLOWED INNOVATIVE NEW RESEARCH IN PROGERIA TO THRIVE.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0154166
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt022496
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt013
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0112784
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt031960
IRS990/FeesForServicesAccountingGrp/TotalAmt031960
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt05010
IRS990/FeesForServicesLegalGrp/TotalAmt05010
IRS990/FeesForServicesOtherGrp/FundraisingAmt014592
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt08550
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt06328
IRS990/FeesForServicesOtherGrp/TotalAmt029470
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt041875
IRS990/ForeignGrantsGrp/TotalAmt041875
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt101.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt924027
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/PersonNm0SCOTT BERNS
IRS990/Form990PartVIISectionAGrp/PersonNm1PAULA KELLY
IRS990/Form990PartVIISectionAGrp/PersonNm2KAREN BALLACK
IRS990/Form990PartVIISectionAGrp/PersonNm3SANDRA BRESNICK
IRS990/Form990PartVIISectionAGrp/PersonNm4KIM PARATORE
IRS990/Form990PartVIISectionAGrp/PersonNm5JOHN MAROZZI
IRS990/Form990PartVIISectionAGrp/PersonNm6LARRY MILLS
IRS990/Form990PartVIISectionAGrp/PersonNm7TOM O'BRIEN
IRS990/Form990PartVIISectionAGrp/PersonNm8LIZA MORRIS
IRS990/Form990PartVIISectionAGrp/PersonNm9AUDREY GORDON
IRS990/Form990PartVIISectionAGrp/PersonNm10BARBARA GORDON
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9122669
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1TREASURER/DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt10CLERK
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01999
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0204286
IRS990/FundraisingDirectExpensesAmt039817
IRS990/FundraisingGrossIncomeAmt0204798
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt09
IRS990/GovernmentGrantsAmt045366
IRS990/GrantAmt0112784
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt070909
IRS990/GrantsToDomesticOrgsGrp/TotalAmt070909
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt05086605
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt08
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt06075
IRS990/InsuranceGrp/TotalAmt06075
IRS990/IntangibleAssetsGrp/BOYAmt091598
IRS990/IntangibleAssetsGrp/EOYAmt089454
IRS990/InvestmentIncomeGrp/ExclusionAmt0102997
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0102997
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt0216103
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt0511136
IRS990/IRPDocumentCnt07
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt048179
IRS990/LandBldgEquipBasisNetGrp/BOYAmt016759
IRS990/LandBldgEquipBasisNetGrp/EOYAmt044011
IRS990/LandBldgEquipCostOrOtherBssAmt092190
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd01
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0DISCOVER TREATMENTS & CURE FOR PROGERIA & ITS AGING RELATED DISORDERS, INCLUDING HEART DISEASE.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt04542139
IRS990/NetAssetsOrFundBalancesEOYAmt06942443
IRS990/NetIncmFromFundraisingEvtGrp/ExclusionAmt0164981
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt0164981
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt04387973
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt06919947
IRS990/NoncashContributionsAmt099510
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt040320
IRS990/OccupancyGrp/ProgramServicesAmt09966
IRS990/OccupancyGrp/TotalAmt050286
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt020637
IRS990/OfficeExpensesGrp/TotalAmt020637
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt03000
IRS990/OtherAssetsTotalGrp/EOYAmt03000
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt08125
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt016846
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt029674
IRS990/OtherEmployeeBenefitsGrp/TotalAmt054645
IRS990/OtherExpensesGrp/Desc0DRUG TRIAL
IRS990/OtherExpensesGrp/Desc1FUTURE TRIAL EFFORTS
IRS990/OtherExpensesGrp/Desc2RESEARCH ACTIVITIES
IRS990/OtherExpensesGrp/Desc3CELL AND TISSUE BANK
IRS990/OtherExpensesGrp/ProgramServicesAmt0559654
IRS990/OtherExpensesGrp/ProgramServicesAmt1353760
IRS990/OtherExpensesGrp/ProgramServicesAmt2282855
IRS990/OtherExpensesGrp/ProgramServicesAmt398014
IRS990/OtherExpensesGrp/TotalAmt0559654
IRS990/OtherExpensesGrp/TotalAmt1353760
IRS990/OtherExpensesGrp/TotalAmt2282855
IRS990/OtherExpensesGrp/TotalAmt398014
IRS990/OtherLiabilitiesGrp/BOYAmt00
IRS990/OtherLiabilitiesGrp/EOYAmt027453
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt083155
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0133135
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0252609
IRS990/OtherSalariesAndWagesGrp/TotalAmt0468899
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt010154
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt016178
IRS990/PayrollTaxesGrp/ProgramServicesAmt035830
IRS990/PayrollTaxesGrp/TotalAmt062162
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0188738
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0151293
IRS990/PoliciesReferenceChaptersInd01
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt018908
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt042569
IRS990/PrincipalOfficerNm0AUDREY GORDON ESQ
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0PROGERIA DRUG TRIAL: THE PROGERIA RESEARCH FOUNDATION AND CHILDREN'S HOSPITAL BOSTON CONTINUE THEIR PARTNERSHIP FOR CONDUCTING CLINICAL DRUG TRIALS FOR CHILDREN WITH PROGERIA.THE CLINICAL TRIAL TEAM: A TEAM OF PROFESSIONALS AT CHILDREN'S HOSPITAL BOSTON AND BRIGHAM & WOMEN'S HOSPITAL IS WORKING WITH CHILDREN WITH PROGERIA FROM AROUND THE GLOBE. MEMBERS OF THE TEAM HAVE EXPERTISE NOT ONLY IN PROGERIA, BUT ALSO IN THE DRUGS ADMINISTERED IN THE TRIALS.(SEE SCHEDULE O FOR CONTINUATION) THE PROGERIA TRIPLE DRUG TRIALIN 2007, RESEARCHERS IDENTIFIED TWO DRUGS CALLED PRAVASTATIN AND ZOLEDRONATE THAT, WHEN USED IN COMBINATION WITH THE FTI DRUG THAT WAS TESTED IN THE FIRST-EVER PROGERIA CLINICAL DRUG TRIAL, MIGHT PROVIDE AN EVEN MORE EFFECTIVE TREATMENT FOR CHILDREN WITH PROGERIA THAN FTI'S ALONE.IN 2014, THE TRIPLE DRUG TRIAL DESIGN WAS AMENDED BASED ON THE CONTINUAL RE-EVALUATION OF TRIAL PROTOCOL AND THE RESULTS OF THE FIRST TRIAL SHOWING THE EFFECTIVENESS OF ONE OF THE THREE DRUGS TESTED. THE TRIAL TEAM DETERMINED THAT THE BEST COURSE OF ACTION WAS TO CONTINUE STUDYING THE EFFECTS OF LONAFARNIB ALONE FOR A PERIOD OF 2 YEARS, AND EXPAND ENROLLMENT TO UP TO 80 PARTICIPANTS. THE APPROPRIATE APPROVALS WERE SECURED, AND CHANGES IMPLEMENTED AND THE PROGRESS IN 2015-2017 IS DETAILED BELOW. IN 2015, 15 ADDITIONAL TRIAL SUBJECTS ENROLLED FROM 13 COUNTRIES SPEAKING 10 DIFFERENT LANGUAGES. IN 2016, 3 ADDITIONAL TRIAL SUBJECTS ENROLLED FROM 3 COUNTRIES. DURING 2017, PRF AND THE TRIAL TEAM CONTINUED TO WORK WITH OTHER FAMILIES TOWARD TRIAL PARTICIPATION, INCLUDING SEVERAL NEWLY DIAGNOSED CHILDREN. THE PROGERIA 2-DRUG, PHASE I/II TRIALIN 2015, PRF OBTAINED ALL NECESSARY APPROVALS FOR ITS THIRD CLINICAL TRIAL WHICH WILL ASSESS A TWO-DRUG COMBINATION OF LONAFARNIB AND EVEROLIMUS. EVEROLIMUS IS A FORM OF THE DRUG RAPAMYCIN, BUT EVEROLIMUS CAN BE MORE EASILY GIVEN TO CHILDREN WITH PROGERIA. EVEROLIMUS TARGETS A DIFFERENT PATHWAY THAN LONAFARNIB AND THE TRIAL IS DESIGNED TO DETERMINE IF THE COMBINATION PROVIDES A BETTER TREATMENT THAN LONAFARNIB ON ITS OWN. THE PROGRESS OF THIS TRIAL IN 2016 IS DETAILED BELOW.IN 2016, 15 TRIAL PARTICIPANTS ENROLLED IN PHASE I OF THIS TRIAL FROM 6 COUNTRIES SPEAKING 6 DIFFERENT LANGUAGES. THE PURPOSE OF A PHASE I TRIAL IS TO DETERMINE THE SAFEST MAXIMUM DOSAGE OF A DRUG.IN 2017, THE 17 CHILDREN THAT PARTICIPATED IN PHASE I OF THE DRUG TRIAL HAVE BEED MOVED ONTO PHASE 2. PHASE II OF THE TRIAL TESTS THE EFFECTIVENESS OF THE 2-DRUG COMBINATION. THE ENROLLMENT OF ADDITIONAL CHILDREN TOOK PLACE IN JULY OF 2017. 39 CHILDREN FROM 18 DIFFERENT COUNTRIES TRAVELED TO BOSTON TO PARTICIPATE IN THE DRUG TRIAL.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0559654
IRS990/ProgSrvcAccomActy3Grp/Desc0FUTURE TRIAL EFFORTS: PRF ENGAGES MEMBERS IN THE SCIENTIFIC COMMUNITY WITH EXPERTISE IN VARIOUS DRUGS AND/OR GENETIC THERAPIES FOR THE TREATMENT AND POTENTIAL CURE FOR PROGERIA. THE INVESTIGATION AND COLLABORATIVE EVALUATION OF DRUG THERAPIES IS PURSUED TO IDENTIFY DRUG CANDIDATES/GENETIC THERAPIES THAT CAN LEAD TO FUTURE CLINICAL TRIALS.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0353760
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt01118720
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02842968
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0460750
IRS990/PYInvestmentIncomeAmt047164
IRS990/PYOtherExpensesAmt01426552
IRS990/PYOtherRevenueAmt0-5415
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0363198
IRS990/PYSalariesCompEmpBnftPaidAmt0634217
IRS990/PYTotalExpensesAmt02521519
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02884717
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt02400304
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt04490236
IRS990/SavingsAndTempCashInvstGrp/EOYAmt06609595
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt04943791
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02837553
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02100210
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt03121557
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01957893
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt014961004
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0102997
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt047164
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt047077
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt050942
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt058026
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0306206
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.74540
IRS990ScheduleA/PublicSupportPY170Pct00.86540
IRS990ScheduleA/PublicSupportTotal170Amt011380076
IRS990ScheduleA/SubstantialContributorsTotAmt03580928
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt04943791
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02837553
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02100210
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt03121557
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01957893
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt014961004
IRS990ScheduleA/TotalSupportAmt015267210
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt0387862
IRS990ScheduleD/DonatedServicesUseFcltsAmt0387862
IRS990ScheduleD/EquipmentGrp/BookValueAmt039808
IRS990ScheduleD/EquipmentGrp/DepreciationAmt045250
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt085058
IRS990ScheduleD/ExpensesNotReportedAmt0387862
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02646484
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt04203
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt02929
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt07132
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt027453
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0REFUNDABLE ADVANCES
IRS990ScheduleD/OtherSecuritiesGrp/BookValueAmt0511136
IRS990ScheduleD/OtherSecuritiesGrp/Desc0THE STANDARD ANNUITY
IRS990ScheduleD/OtherSecuritiesGrp/MethodValuationCd0F
IRS990ScheduleD/RevenueNotReportedAmt0387862
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt00
IRS990ScheduleD/RevenueSubtotalAmt05046788
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE ORGANIZATION ACCOUNTS FOR THE UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE PROVISIONS OF FASB ASC TOPIC NO. 740 INCOME TAXES (ASC 740), WHICH PRESCRIBES A RECOGNITION THRESHOLD OF MORE LIKELY-THAN-NOT, AND A MEASUREMENT ATTRIBUTE FOR ALL TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN ON A TAX RETURN, IN ORDER FOR THOSE TAX POSITIONS TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS. WHEN NECESSARY, THE ORGANIZATION ACCOUNTS FOR INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS AS PART OF ITS PROVISION FOR INCOME TAXES. THE ORGANIZATION DOES NOT EXPECT THAT UNRECOGNIZED TAX BENEFITS ARISING FROM TAX POSITIONS WILL CHANGE SIGNIFICANTLY WITHIN THE NEXT 12 MONTHS.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt044011
IRS990ScheduleD/TotalBookValueSecuritiesAmt0511136
IRS990ScheduleD/TotalExpensesPerForm990Amt02646484
IRS990ScheduleD/TotalLiabilityAmt027453
IRS990ScheduleD/TotalRevenuePerForm990Amt05046788
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt05434650
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt03034346
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt023125
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0GRANT MAKING
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt041875
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0MEDICAL RESEARCH
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt023125
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0METHOD OF ACCOUNTING IS ACCRUAL.
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt1PRF USES THE SAME PROCEDURES FOR MONITORING GRANTS OUTSIDE THE US THAT IT USES FOR GRANTS MADE WITHIN THE US. THE PROCEDURE IS DESCRIBED IN PART IV OF SCHEDULE I.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0PART III ACCOUNTING METHOD:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1PART II, LINE 1
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc2PART I, LINE 2:
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$48.0$0.63$47.4$3.65$5.90$2.25
2023Detailed filing. Detailed filing data is available for this year.$48.8$0.59$48.3$2.23$3.93$1.70
2022Detailed filing. Detailed filing data is available for this year.$47.6$0.77$46.8$1.79$3.13$1.33
2021Detailed filing. Detailed filing data is available for this year.$53.7$0.34$53.4$49.2$3.16$46.1
2020Detailed filing. Detailed filing data is available for this year.$6.95$0.42$6.53$2.21$2.62$0.41
2019Detailed filing. Detailed filing data is available for this year.$7.45$0.51$6.94$5.05$2.65$2.40
2018Detailed filing. Detailed filing data is available for this year.$5.03$0.48$4.54$2.88$2.52$0.36
2017Detailed filing. Detailed filing data is available for this year.$4.51$0.33$4.18$2.15$2.36$0.22
2016Detailed filing. Detailed filing data is available for this year.$4.78$0.39$4.39$3.17$2.65$0.52
2015Summary only. Only limited summary data is available for this year.$4.31$0.43$3.87$2.02$2.82$0.81
2014Summary only. Only limited summary data is available for this year.$5.08$0.43$4.65$2.74$2.58$0.16
2013Summary only. Only limited summary data is available for this year.$4.23$0.20$4.03$2.72$2.37$0.35
2012Summary only. Only limited summary data is available for this year.$3.74$0.05$3.69$1.81$1.58$0.23
2011Summary only. Only limited summary data is available for this year.$3.56$0.11$3.45$2.03$1.37$0.66
2010Summary only. Only limited summary data is available for this year.$2.82$0.03$2.79$1.70$1.24$0.46